I-Mab (IMAB) Short Interest Ratio & Short Volume $0.98 +0.03 (+3.16%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends I-Mab Short Interest DataI-Mab (IMAB) has a short interest of 591,200 shares. This marks a 20.26% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 408,961 shares to cover all short positions.Current Short Interest591,200 sharesPrevious Short Interest491,600 sharesChange Vs. Previous Month+20.26%Dollar Volume Sold Short$632,584.00Short Interest Ratio1.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares81,430,000 sharesPercentage of Shares Shorted0.73%Today's Trading Volume159,867 sharesAverage Trading Volume408,961 sharesToday's Volume Vs. Average39% Short Selling I-Mab? Sign up to receive the latest short interest report for I-Mab and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMAB Short Interest Over TimeIMAB Days to Cover Over TimeIMAB Percentage of Float Shorted Over Time Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! I-Mab Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024591,200 shares $632,584.00 +20.3%N/A1.6 $1.07 10/15/2024491,600 shares $658,744.00 -7.8%N/A1.5 $1.34 9/30/2024533,100 shares $661,044.00 -12.0%N/A1.8 $1.24 9/15/2024605,700 shares $642,042.00 -15.5%N/A3 $1.06 8/31/2024716,600 shares $809,758.00 -15.9%N/A3.7 $1.13 8/15/2024852,300 shares $937,530.00 -8.2%N/A3.6 $1.10 Get the Latest News and Ratings for IMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024928,300 shares $1.29 million -11.6%N/A4.1 $1.39 7/15/20241,050,000 shares $1.71 million -2.8%N/A4.9 $1.63 6/30/20241,080,000 shares $1.80 million -3.6%N/A5.2 $1.67 6/15/20241,120,000 shares $2.06 million -8.9%N/A4.9 $1.84 5/31/20241,230,000 shares $2.04 million +4.2%N/A4.7 $1.66 5/15/20241,180,000 shares $2.15 million +1.7%N/A4.8 $1.82 4/30/20241,160,000 shares $2.05 million -10.8%N/A3.6 $1.77 4/15/20241,300,000 shares $2.34 million +11.1%N/A3.4 $1.80 3/31/20241,170,000 shares $2.18 million +7.3%N/A2.7 $1.86 3/15/20241,090,000 shares $2.03 million +1.9%N/A2 $1.86 2/29/20241,070,000 shares $1.90 million -5.3%N/A1.9 $1.78 2/15/20241,130,000 shares $2.00 million -28.0%N/A2 $1.77 1/31/20241,570,000 shares $2.78 million +4.0%N/A2.6 $1.77 1/15/20241,510,000 shares $3.10 million -6.8%N/A2.4 $2.05 12/31/20231,620,000 shares $3.08 million -11.5%N/A2.5 $1.90 12/15/20231,830,000 shares $2.54 million -1.6%N/A3.1 $1.39 11/30/20231,860,000 shares $2.90 million -2.6%N/A2.7 $1.56 11/15/20231,910,000 shares $3.29 million No ChangeN/A2.5 $1.72 10/31/20231,910,000 shares $2.73 million +26.5%N/A2.4 $1.43 10/15/20231,510,000 shares $2.02 million +11.0%N/A2.2 $1.34 9/30/20231,360,000 shares $1.80 million -25.3%N/A2.1 $1.32 9/15/20231,820,000 shares $2.44 million +11.7%N/A3 $1.34 8/31/20231,630,000 shares $3.10 million -0.6%N/A3.5 $1.90 8/15/20231,640,000 shares $3.92 million +7.9%N/A4.8 $2.39 7/31/20231,520,000 shares $4.38 million -4.4%N/A5 $2.88 7/15/20231,590,000 shares $4.44 million +3.9%N/A5.3 $2.79 6/30/20231,530,000 shares $4.57 million -1.9%N/A5.4 $2.99 6/15/20231,560,000 shares $4.80 million +0.7%N/A4.6 $3.08 5/31/20231,550,000 shares $4.81 million -5.5%N/A4.5 $3.10 5/15/20231,640,000 shares $5.33 million -13.7%N/A4.7 $3.25 4/30/20231,900,000 shares $5.85 million -5.9%N/A5.1 $3.08 4/15/20232,020,000 shares $7.11 million +8.6%N/A5.1 $3.52 3/31/20231,860,000 shares $6.44 million +10.1%N/A3.9 $3.46 3/15/20231,690,000 shares $6.54 million -7.1%N/A2.9 $3.87Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 2/28/20231,820,000 shares $7.83 million -6.7%N/A3.1 $4.30 2/15/20231,950,000 shares $8.89 million -16.7%N/A3.3 $4.56 1/31/20232,340,000 shares $14.09 million +13.0%N/A3.9 $6.02 1/15/20232,070,000 shares $15.30 million +9.5%N/A3.7 $7.39 12/30/20221,890,000 shares $7.90 million -3.1%N/A3.4 $4.18 12/15/20221,950,000 shares $7.29 million +3.7%N/A4.7 $3.74 11/30/20221,880,000 shares $6.96 million -11.7%N/A4.2 $3.70 11/15/20222,130,000 shares $10.35 million +2.9%N/A4.2 $4.86 10/31/20222,070,000 shares $7.68 million -5.9%N/A3.3 $3.71 10/15/20222,200,000 shares $8.21 million -22.8%N/A3.2 $3.73 9/30/20222,850,000 shares $11.43 million +9.2%N/A4.4 $4.01 9/15/20222,610,000 shares $14.15 million -2.3%N/A4 $5.42 8/31/20222,670,000 shares $16.37 million -2.9%N/A3.9 $6.13 8/15/20222,750,000 shares $21.92 million -6.8%N/A3.2 $7.97 7/31/20222,950,000 shares $30.92 million -15.0%N/A3.4 $10.48 7/15/20223,470,000 shares $31.06 million +11.9%N/A3.7 $8.95 6/30/20223,100,000 shares $35.03 million +1.6%N/A2.6 $11.30 6/15/20223,050,000 shares $29.86 million -13.4%N/A2.3 $9.79 5/31/20223,520,000 shares $30.62 million -9.3%N/A2.4 $8.70 5/15/20223,880,000 shares $46.56 million -4.4%N/A3 $12.00 4/30/20224,060,000 shares $50.91 million +8.9%N/A3.2 $12.54 4/15/20223,730,000 shares $49.68 million -3.4%N/A2.9 $13.32 3/31/20223,860,000 shares $62.69 million -8.8%N/A3.7 $16.24 3/15/20224,230,000 shares $57.02 million +6.6%N/A4.9 $13.48 2/28/20223,970,000 shares $98.14 million +5.0%N/A5.4 $24.72 2/15/20223,780,000 shares $105.16 million +14.2%N/A5.5 $27.82 1/31/20223,310,000 shares $83.58 million +18.6%N/A5.3 $25.25 1/15/20222,790,000 shares $97.82 million -18.9%N/A0 $35.06 12/31/20213,440,000 shares $163.02 million +31.3%N/A7.4 $47.39 12/15/20212,620,000 shares $123.06 million -0.4%N/A5.3 $46.97 11/30/20212,630,000 shares $159.01 million -1.9%N/A5.3 $60.46 11/15/20212,680,000 shares $162.92 million +7.6%N/A5.2 $60.79 10/29/20212,490,000 shares $153.86 million -1.2%N/A4.5 $61.79 10/15/20212,520,000 shares $165.89 million +18.9%N/A4 $65.83 9/30/20212,120,000 shares $153.68 million +6.5%N/A3.2 $72.49 9/15/20211,990,000 shares $135.56 million +8.7%N/A3.2 $68.12 8/31/20211,830,000 shares $129.78 million -4.7%2.6%3.1 $70.92 8/13/20211,920,000 shares $134.75 million -8.6%2.6%2.9 $70.18 7/30/20212,100,000 shares $163.97 million +18.0%2.8%3 $78.08 7/15/20211,780,000 shares $132.00 million -16.8%N/A2.9 $74.16 6/30/20212,140,000 shares $179.65 million -0.9%N/A3.6 $83.95 6/15/20212,160,000 shares $151.93 million +9.1%N/A3.8 $70.34 5/28/20211,980,000 shares $160.52 million +39.4%N/A3.6 $81.07 5/14/20211,420,000 shares $88.15 million +2.2%N/A3.1 $62.08 4/30/20211,390,000 shares $83.40 million -11.5%N/A3.4 $60.00 4/15/20211,570,000 shares $86.49 million +52.4%N/A4.2 $55.09 3/31/20211,030,000 shares $48.59 million +46.3%N/A2.9 $47.17 3/15/2021704,000 shares $38.73 million +21.8%N/A2.1 $55.01 2/26/2021578,000 shares $33.80 million -19.0%N/A1.8 $58.48 2/12/2021713,300 shares $41.00 million -8.9%N/A2.6 $57.48Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. 1/29/2021782,800 shares $40.91 million -9.4%N/A2.9 $52.26 1/15/2021864,100 shares $43.00 million No ChangeN/A3.3 $49.76 IMAB Short Interest - Frequently Asked Questions What is I-Mab's current short interest? Short interest is the volume of I-Mab shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 591,200 shares of IMAB short. Learn More on I-Mab's current short interest. What is a good short interest ratio for I-Mab? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMAB shares currently have a short interest ratio of 2.0. Learn More on I-Mab's short interest ratio. Is I-Mab's short interest increasing or decreasing? I-Mab saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 591,200 shares, an increase of 20.3% from the previous total of 491,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does I-Mab's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to I-Mab: Design Therapeutics, Inc. (8.07%), Lyell Immunopharma, Inc. (8.93%), Sage Therapeutics, Inc. (11.91%), Kodiak Sciences Inc. (2.67%), ProQR Therapeutics (0.83%), Immutep Limited (3.44%), Rezolute, Inc. (1.93%), iTeos Therapeutics, Inc. (11.11%), Voyager Therapeutics, Inc. (5.40%), C4 Therapeutics, Inc. (8.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short I-Mab stock? Short selling IMAB is an investing strategy that aims to generate trading profit from I-Mab as its price is falling. IMAB shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against I-Mab? A short squeeze for I-Mab occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMAB, which in turn drives the price of the stock up even further. How often is I-Mab's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMAB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies DSGN Short Squeeze LYEL Short Squeeze SAGE Short Squeeze KOD Short Squeeze PRQR Short Squeeze IMMP Short Squeeze RZLT Short Squeeze ITOS Short Squeeze VYGR Short Squeeze CCCC Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMAB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Please log in to your account or sign up in order to add this asset to your watchlist. Share I-Mab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMAB Stock Alerts